Drug Information

Drug General Information
Drug ID
D00DDH
Former ID
DNC013234
Drug Name
(2S)-aminobutyryl-L-proline-(2S)-methylbutylamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527857]
Structure
Download
2D MOL

3D MOL
Formula
C14H27N3O2
Canonical SMILES
CCC(C)CNC(=O)C1CCCN1C(=O)C(CC)N
InChI
1S/C14H27N3O2/c1-4-10(3)9-16-13(18)12-7-6-8-17(12)14(19)11(15)5-2/h10-12H,4-9,15H2,1-3H3,(H,16,18)/t10-,11-,12-/m0/s1
InChIKey
KKFKEHDSJNUMHG-SRVKXCTJSA-N
PubChem Compound ID
11623159
Target and Pathway
Target(s) Tripeptidyl-peptidase II Target Info Inhibitor [527857]
Reactome Antigen processing: Ubiquitination & Proteasome degradation
References
Ref 527857J Med Chem. 2005 Nov 17;48(23):7333-42.Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach to designing exopeptidase inhibitors.
Ref 527857J Med Chem. 2005 Nov 17;48(23):7333-42.Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach to designing exopeptidase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.